Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Alvotech SA before investing.

In this article, we go over a few key elements for understanding Alvotech SA’s stock price such as:

• Alvotech SA’s current stock price and volume
• Why Alvotech SA’s stock price changed recently
• Upgrades and downgrades for ALVO from analysts
• ALVO’s stock price momentum as measured by its relative strength

About Alvotech SA (ALVO)

Before we jump into Alvotech SA’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Alvotech SA is a biotechnology company. The Company is focused on the development and manufacture of biosimilar medicines for patients globally. It is engaged in developing a pipeline of monoclonal antibodies that target a variety of therapeutic areas including inflammatory diseases, oncology, and ophthalmology. The Company’s pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Its products pipeline includes AVT02, AVT04, AVT23, AVT03, AVT05, AVT06, AVT16, and AVT33. Its AVT02 is a monoclonal antibody and a biosimilar to Humira (adalimumab). AVT04 is a monoclonal antibody and a biosimilar candidate to Stelara (ustekinumab). It has formed a network of strategic commercial partnerships to provide global reach and leverage expertise in markets that include the United States (U.S.), Europe, Japan, China, and other Asian countries and large parts of South America, Africa, and the Middle East.

Want to learn more about Alvotech SA’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Alvotech SA.

Alvotech SA’s Stock Price as of Market Close

As of March 26, 2024, 4:00 PM, CST, Alvotech SA’s stock price was $12.50.

Alvotech SA is down 5.8% from its previous closing price of $13.27.

During the last market session, Alvotech SA’s stock traded between $13.16 and $14.29. Currently, there are 226.78 million shares of Alvotech SA stock available for purchase.

Unfortunately, Alvotech SA’s P/E ratio is not significant enough to use for stock price evaluation. We recommend investors evaluate other financial metrics to understand its overall valuation.

Alvotech SA Stock Price History

Alvotech SA’s (ALVO) price is currently down 18.78% so far this month.

During the month of March, Alvotech SA’s stock price has reached a high of $16.95 and a low of $12.46.

Over the last year, Alvotech SA has hit prices as high as $18.00 and as low as $6.70. Year to date, Alvotech SA’s stock is up 25%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Alvotech SA Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of March 25, 2024, there were 0 analysts who downgraded Alvotech SA’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate Alvotech SA’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Alvotech SA’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Alvotech SA (ALVO) by visiting AAII Stock Evaluator.

Relative Price Strength of Alvotech SA

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of March 25, 2024, Alvotech SA has a weighted four-quarter relative price strength of -0.01%, which translates to a Momentum Score of 70 and is considered to be Strong.

Want to learn more about how Alvotech SA is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Alvotech SA Stock Price: Bottom Line

As of March 26, 2024, Alvotech SA’s stock price is $12.50, which is down 5.8% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Alvotech SA stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.